Energy and Commerce Committee

Oversight and Investigations

Walden Remarks at Oversight Hearing on Protecting U.S. Drug Supply Chain


WASHINGTON, DC – Energy and Commerce Committee Republican Leader Greg Walden (R-OR) remarks at a Oversight and Investigations Subcommittee hearing titled "Securing the U.S. Drug Supply Chain: Oversight of FDA’s Foreign Inspection Program."

As Prepared for Delivery

Chair DeGette, thank you for this hearing. Our drugs and drug ingredients more and more come from overseas, especially from China and India. Manufacturers have ultimate responsibility for the safety and effectiveness of these products. But FDA has an indispensable role to protect public health by ensuring that drug firms are complying with good manufacturing practices. Through...

Press Release

Energy and Commerce Republican Leaders Press Insurers on Rising Insulin Prices


WASHINGTON, DC – Energy and Commerce Committee Republican Leader Greg Walden (R-OR), Oversight and Investigations Subcommittee Republican Leader Brett Guthrie (R-KY), and Health Subcommittee Republican Leader Michael Burgess.(R-TX) are pressing top insurance companies for answers as to their role in the rising cost of insulin.

In letters to Anthem, Blue Cross Blue Shield, CVS Health, Cigna Corporation, Kaiser Permanente, and UnitedHealth Group, the leaders request information on the relationship between insulin's list price and its negotiated price and the impact this negotiation process has on patients.

"We are continuing to investigate...

Press Release

Letter to insurers on rising price of insulin


Excerpt: "Unfortunately, even though the average net price that manufacturers are receiving for many insulin products is decreasing and PBMs are working with health plans to help reduce the cost of insulin for health plans, many Americans are facing increased out-of-pocket costs for their insulin at the pharmacy counter," the leaders wrote in their letters. "We are therefore examining the role of insurers in the prescription drug supply chain, including questions about how insurers make decisions about plan design, the use of rebates in the insulin market, and the...


Oversight and Investigations


Responsible for conducting oversight and investigations of any matter related to the jurisdiction of the full committee.